TKNO

10.81% -0.59

Handel nachbörslich: 4.99 0.12 +2.46%

Alpha Teknova Inc (TKNO)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Alpha Teknova Inc Stock (TKNO) Company Profile

Alpha Teknova Inc

Healthcare (1183)

(831) 637-1100

2451 BERT DRIVE, HOLLISTER

Nächster Verdiensttermin

Neueste SEC-Einreichungen

TKNO's Discussions on Twitter

Vergleichen Sie TKNO mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TKNO Alpha Teknova Inc	4.87	271.19M	36.68M	-36.78M	-26.75M	-1.16
ZTS Zoetis Inc	159.61	73.88B	9.26B	2.49B	2.30B	5.47
TAK Takeda Pharmaceutical Co Adr	15.19	48.17B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	10.45	47.59B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	14.85	17.28B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	307.37	13.78B	2.76B	1.11B	898.10M	22.77

Alpha Teknova Inc Stock (TKNO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-02-10	Eingeleitet	Craig Hallum	Buy
2024-03-12	Herabstufung	BTIG Research	Buy → Neutral

Alpha Teknova Inc Aktie (TKNO) Neueste Nachrichten

Finanzdaten der Alpha Teknova Inc-Aktie (TKNO)

Alpha Teknova Inc (TKNO)

Alpha Teknova Inc Stock (TKNO) Company Profile

Vergleichen Sie TKNO mit anderen Aktien

Alpha Teknova Inc Stock (TKNO) Upgrades & Downgrades

Alpha Teknova Inc Aktie (TKNO) Neueste Nachrichten

(TKNO) On The My Stocks Page - news.stocktradersdaily.com

Teknova And Pluristyx Launch PluriFreeze Cryopreservation System To Streamline Cell Therapy - Nasdaq

Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies - The Manila Times

Revolutionary Cell Therapy Preservation: Teknova's New PluriFreeze System Transforms Development Process - StockTitan

How the (TKNO) price action is used to our Advantage - news.stocktradersdaily.com

Alpha Teknova, Inc. (NASDAQ:TKNO) Sees Large Increase in Short Interest - Defense World

Sector Update: Health Care Stocks Decline Wednesday Afternoon - TradingView

Sector Update: Health Care -March 12, 2025 at 08:46 am EDT - Marketscreener.com

Alpha Teknova, Pluristyx Partner to Produce, Distribute PluriFreeze for Cell Therapies -March 12, 2025 at 04:23 am EDT - Marketscreener.com

Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies - The Manila Times

Alpha Teknova and Pluristyx Announce Collaboration to Commercialize PluriFreeze Cryopreservation System for Cell Therapies - Nasdaq

Teknova, Pluristyx announce collaboration over next-generation cell therapies - TipRanks

Earnings Update: Here's Why Analysts Just Lifted Their Alpha Teknova, Inc. (NASDAQ:TKNO) Price Target To US$10.67 - Yahoo Finance

Alpha Teknova, Inc. SEC 10-K Report - TradingView

Alpha Teknova, Inc. (NASDAQ:TKNO) Just Reported And Analysts Have Been Lifting Their Price Targets - Simply Wall St

Alpha Teknova’s Earnings Call: Growth Amid Challenges - TipRanks

Alpha Teknova, Inc. (NASDAQ:TKNO) Q4 2024 Earnings Call Transcript - MSN

Positive Outlook for Alpha Teknova: Strong Financial Performance and Growth Potential - TipRanks

Alpha Teknova stock holds as KeyBanc maintains rating By Investing.com - Investing.com South Africa

Alpha Teknova stock holds as KeyBanc maintains rating - Investing.com India

Alpha Teknova: Strong Revenue Growth and Strategic Positioning Justify Buy Rating - TipRanks

Teknova Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times

Alpha Teknova: Q4 Earnings Snapshot - Midland Daily News

Alpha Teknova Reports Steady Revenue Growth in 2024 - TipRanks

Earnings call transcript: Alpha Teknova Q4 2024 shows revenue growth, stock edges up - Investing.com India

Alpha Teknova: Q4 Earnings Snapshot -March 04, 2025 at 05:12 pm EST - Marketscreener.com

Alpha Teknova, Inc. Q4 Loss Narrows - Nasdaq

Alpha Teknova, Inc. Reports 3% Revenue Growth for 2024 and Provides 2025 Guidance of $39-42 Million - Nasdaq

Can Teknova's 110% Clinical Solutions Growth Offset Continued Losses? - StockTitan

Stock Index Futures Mixed as Investors Weigh Trump Tariffs - TradingView

Alpha Teknova, Inc. (NASDAQ:TKNO) Short Interest Up 54.3% in February - Defense World

Alpha Teknova, Inc. (NASDAQ:TKNO) Stocks Pounded By 31% But Not Lagging Industry On Growth Or Pricing - Simply Wall St

Calculating The Fair Value Of Alpha Teknova, Inc. (NASDAQ:TKNO) - Simply Wall St

When the Price of (TKNO) Talks, People Listen - Stock Traders Daily

Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - The Manila Times

Alpha Teknova, Inc. Scheduled to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - Nasdaq

Q4 Earnings: Can Teknova's Critical Reagents Business Show Growth Momentum? - StockTitan

Nkcfo LLC Makes New Investment in Alpha Teknova, Inc. (NASDAQ:TKNO) - MarketBeat

Leading Driver In The Ready-To-Use Luria-Bertani LB Liquid Medium Market 2025: Surge In R&D Activities Driving - EIN News

Oruka Therapeutics (NASDAQ:ORKA) & Alpha Teknova (NASDAQ:TKNO) Head-To-Head Contrast - Defense World

Alpha Teknova (NASDAQ:TKNO) Shares Gap UpTime to Buy? - MarketBeat

Alpha Teknova (NASDAQ:TKNO) Earns Buy Rating from Analysts at Craig Hallum - MarketBeat

(TKNO) Technical Data - Stock Traders Daily

Here’s What Boosted Alpha Teknova (TKNO) in Q4 - Yahoo Finance

Craig-Hallum initiates Alpha Teknova stock with buy rating - MSN

Finanzdaten der Alpha Teknova Inc-Aktie (TKNO)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie TKNO